“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Dimitri P. Mikhailidis(UCL Australia), Evangelos Liberopoulos(University of Patras), Giovam Battista Rini(University of Palermo), Klaus G. Parhofer(LMU Klinikum), Matilda Florentin(University of Ioannina), Kaspar Berneis, Alexandros D. Tselepis(University of Ioannina), G. H. Tomkin(Trinity College Dublin), Manfredi Rizzo(University of Palermo), Moses Elisaf(University of Ioannina), Anthony S. Wierzbicki(King's College London), Giatgen A. Spinas(Core Laboratories (United States)), Alberto Zambon(University of Padua), Vasilios G. Athyros(Neurosciences Institute), Bruce A. Griffin(University of Surrey), Winfried März(Heidelberg University), Karl Winkler(University Medical Center Freiburg), Jacqueline de Graaf(Radboud University Nijmegen)
Cited by 197
Related Papers
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
|European Heart Journal|2014|1.1k
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
|European Heart Journal|2015|868
Association analyses based on false discovery rate implicate new loci for coronary artery disease
|Nature Genetics|2017|792
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726